Clonal hematopoiesis of indeterminate potential and cardiovascular diseases: A review [PDF]
Cardiovascular disease (CVD) is a major driver of mortality and declining health worldwide. Cardiovascular diseases (CVD) is the most common cause of morbidity and mortality globally. Although dyslipidemia, smoking, diabetes, hypertension and obesity are
Nagendra Boopathy Senguttuvan +5 more
doaj +4 more sources
Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View [PDF]
Clonal hematopoiesis of indeterminate potential (CHIP) is a common bone marrow abnormality induced by age‐related DNA mutations, which give rise to proinflammatory immune cells. These immune cells exacerbate atherosclerotic cardiovascular disease and may
Job A J Verdonschot +2 more
exaly +4 more sources
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC
Hematopoietic stem cells (HSCs) ensure the coordinated and balanced production of all hematopoietic cell types throughout life. Aging is associated with a gradual decline of the self-renewal and regenerative potential of HSCs and with the development of
Ugo Testa +2 more
doaj +2 more sources
Risk factors of clonal hematopoiesis of indeterminate potential [PDF]
Background: Accumulating evidence demonstrates associations between clonal hematopoiesis of indeterminate potential (CHIP) and increased risks of haematological and non-haematological health outcomes.
Qiaoxue Liu +6 more
doaj +2 more sources
Clonal Hematopoiesis of Indeterminate Potential: New Insights from Recent Studies
Clonal hematopoiesis of indeterminate potential (CHIP) is a condition characterized by accumulation of one or several somatic mutations in hematopoietic stem cells in the bone marrow.
Adrian Schmidt
doaj +2 more sources
Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease: Gene-Specific Mechanisms and Therapeutic Implications [PDF]
Xuejiao Zhang,1 Hongguang Zhang,2 Jia Fu,2 Shuo Feng,2 Ying Wang31Department of Hematology, The First Hospital of China Medical University, Shenyang, Liaoning, 110001, People’s Republic of China; 2Department of Cardiology, The First Hospital of China ...
Zhang X, Zhang H, Fu J, Feng S, Wang Y
doaj +2 more sources
Clonal hematopoiesis of indeterminate potential and cardiovascular disease: mechanistic insights, clinical implications, and the dawn of precision cardio-hematology [PDF]
Clonal hematopoiesis of indeterminate potential (CHIP) has substantially advanced our understanding of cardiovascular pathogenesis by demonstrating how somatic mutations in hematopoietic stem cells amplify the bone marrow–heart axis to accelerate ...
Hong Wu, Xinyi Meng, Long Li, Chao Zhang
doaj +2 more sources
Clonal hematopoiesis of indeterminate potential and risk of autoimmune thyroid disease [PDF]
Background Autoimmune thyroid disease (AITD) is the most common organ-specific autoimmune disease, often remaining asymptomatic until the thyroid is significantly affected. Clonal hematopoiesis of indeterminate potential (CHIP) has been reported to drive
Xue Zhang +6 more
doaj +2 more sources
Common in atherogenesis and carcinogenesis: clonal hematopoiesis
Clonal hematopoiesis is a common age-dependent state accompanied by the expansion of mutant hematopoietic stem cells as a result of somatic mutations and is associated with a high risk of hematopoietic neoplasms and cardiovascular diseases.
A. A. Sleptsov +2 more
doaj +1 more source
A study of elective genome sequencing and pharmacogenetic testing in an unselected population
Background Genome sequencing (GS) of individuals without a medical indication, known as elective GS, is now available at a number of centers around the United States.
Meagan Cochran +9 more
doaj +1 more source

